학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 372건 | 목록 1~10
Academic Journal
Powles T; Barts Cancer Centre, Barts Health NHS Trust, Queen Mary University of London, London, UK.; Bellmunt J; Department of Hematology and Oncology, Dana-Farber Cancer Institute, Harvard Cancer Centre, Boston, USA.; Comperat E; Department of Pathology, Medical University Vienna, Austria.; De Santis M; Department of Urology, Charité Universitätsmedizin, Berlin, Germany; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Huddart R; Royal Marsden Hospital, Institute of Cancer Research, London, UK.; Loriot Y; Department of Medical Oncology, Université Paris-Saclay and Gustave Roussy, Villejuif, France.; Necchi A; Vita-Salute San Raffaele University, Milan; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.; Valderrama BP; Department of Medical Oncology, University Hospital Virgen del Rocio, Seville, Spain.; Ravaud A; Department of Medical Oncology, Bordeaux University Hospital, Bordeaux, France.; Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York; Department of Urology, University of Texas Southwestern, Dallas, USA; Division of Urology, Department of Special Surgery, University of Jordan, Amman, Jordan.; Szabados B; Barts Cancer Centre, Barts Health NHS Trust, Queen Mary University of London, London, UK; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK.; van der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Gillessen S; Oncology Institute of Southern Switzerland (EOC-IOSI), Bellinzona; Università della Svizzera italiana (USI), Lugano, Switzerland.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Porte F; Health Economics Department, Merck Santé S.A.S., Lyon, France.; Granghaud A; Health Economics department, Pfizer S.A.S., Paris, France.; Chang J; Health Economics department, Pfizer, New York, NY, United States of America.; Kearney M; Global Value Demonstration, Market Access and Pricing, The Healthcare Business of Merck KGaA, Darmstadt, Germany.; Morel A; Health Economics department, Pfizer S.A.S., Paris, France.; Plessala I; Health Economics & Market Access (HEMA), Amaris Consulting, Paris, France.; Cawston H; Health Economics & Market Access (HEMA), Amaris Consulting, Paris, France.; Roiz J; Health Economics, Evidera, London, United Kingdom.; Xiao Y; Health Economics, Evidera, London, United Kingdom.; Solbes MN; Medical Department, Merck Santé S.A.S., Lyon, France.; Lambert P; Medical Department, Pfizer S.A.S., Paris, France.; Ravaud A; Department of Medical Oncology, Centre Hospitalo-Universitaire de Bordeaux, Bordeaux, France.; Loriot Y; Department of Medical Oncology, Institute Gustave-Roussy, Villejuif, France.; Thiery-Vuillemin A; Department of Medical Oncology, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France.; Lévy P; Université Paris-Dauphine, Université-PSL, [LEDA], LEGOS, Paris, France.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Larroquette M; Medical Oncology Department, Hôpital Saint André, University Hospital of Bordeaux, 33076 Bordeaux, France.; Bordeaux University, CNRS UMR 5095, IBGC, 33076 Bordeaux, France.; Lefort F; Medical Oncology Department, Hôpital Saint André, University Hospital of Bordeaux, 33076 Bordeaux, France.; Domblides C; Medical Oncology Department, Hôpital Saint André, University Hospital of Bordeaux, 33076 Bordeaux, France.; ImmunoConcEpt, CNRS UMR 5164, Bordeaux University, 33076 Bordeaux, France.; Héraudet L; Medical Oncology Department, Hôpital Saint André, University Hospital of Bordeaux, 33076 Bordeaux, France.; Robert G; Urology Department, University Hospital of Bordeaux, 33076 Bordeaux, France.; Ravaud A; Medical Oncology Department, Hôpital Saint André, University Hospital of Bordeaux, 33076 Bordeaux, France.; Gross-Goupil M; Medical Oncology Department, Hôpital Saint André, University Hospital of Bordeaux, 33076 Bordeaux, France.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Powles T; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK. t.powles@qmul.ac.uk.; Kockx M; HistogeneX N.V, Wilrijk, Belgium.; Rodriguez-Vida A; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.; Duran I; Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla, Seville, Spain.; Crabb SJ; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.; Van Der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Szabados B; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Pous AF; Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B.ARGO)-IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Gravis G; Institut Paoli-Calmettes, Marseille, France.; Herranz UA; Department of Medical Oncology, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.; Protheroe A; Department of Medical Oncology, Churchill Hospital, Oxford, UK.; Ravaud A; Department of Medical Oncology, Hopital Saint-Andre, University of Bordeaux-CHU Bordeaux, Bordeaux, France.; Maillet D; Department of Medical Oncology, Hospital Lyon Sud, Lyon, France.; Mendez MJ; Department of Medical Oncology, Reina Sofia University Hospital, Cordoba, Spain.; Suarez C; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain.; Linch M; Department of Medical Oncology, University College London Hospital, London, UK.; Prendergast A; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; van Dam PJ; HistogeneX N.V, Wilrijk, Belgium.; Stanoeva D; HistogeneX N.V, Wilrijk, Belgium.; Daelemans S; HistogeneX N.V, Wilrijk, Belgium.; Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium.; Mariathasan S; Genentech, San Francisco, CA, USA.; Tea JS; Genentech, San Francisco, CA, USA.; Mousa K; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Banchereau R; Genentech, San Francisco, CA, USA.; Castellano D; Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Lefort F; Department of Medical Oncology, University Hospital of Bordeaux, 33000 Bordeaux, France.; Rhanine Y; Department of Medical Oncology, University Hospital of Bordeaux, 33000 Bordeaux, France.; Larroquette M; Department of Medical Oncology, University Hospital of Bordeaux, 33000 Bordeaux, France.; Faculty of Medicine, University of Bordeaux, 33000 Bordeaux, France.; Domblides C; Department of Medical Oncology, University Hospital of Bordeaux, 33000 Bordeaux, France.; Faculty of Medicine, University of Bordeaux, 33000 Bordeaux, France.; Heraudet L; Department of Medical Oncology, University Hospital of Bordeaux, 33000 Bordeaux, France.; Sionneau B; Department of Medical Oncology, University Hospital of Bordeaux, 33000 Bordeaux, France.; Lambert S; Department of Medical Oncology, University Hospital of Bordeaux, 33000 Bordeaux, France.; Lasserre M; Department of Medical Oncology, University Hospital of Bordeaux, 33000 Bordeaux, France.; Robert G; Faculty of Medicine, University of Bordeaux, 33000 Bordeaux, France.; Department of Urology, University Hospital of Bordeaux, 33000 Bordeaux, France.; Ravaud A; Department of Medical Oncology, University Hospital of Bordeaux, 33000 Bordeaux, France.; Faculty of Medicine, University of Bordeaux, 33000 Bordeaux, France.; Gross-Goupil M; Department of Medical Oncology, University Hospital of Bordeaux, 33000 Bordeaux, France.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
de Vries-Brilland M; Department of Medical Oncology, Integrated Centers of Oncology (ICO) Paul Papin, Angers, France.; Rioux-Leclercq N; Department of Pathology, University Hospital, Rennes, France.; Meylan M; Equipe inflammation, complément et cancer, Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris-Cité, Paris, France.; Dauvé J; Department of Clinical Biology, Integrated Centers of Oncology (ICO) Paul Papin, Angers, France.; Passot C; Department of Clinical Biology, Integrated Centers of Oncology (ICO) Paul Papin, Angers, France.; Spirina-Menand E; Department of Clinical Biology, Integrated Centers of Oncology (ICO) Paul Papin, Angers, France.; Flippot R; Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Fromont G; Department of Pathology, CHRU, Tours, France.; Gravis G; Medical Oncology, Institut Paoli-Calmettes, Marseille, France.; Geoffrois L; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-les-Nancy, France.; Chevreau C; Department of Medical Oncology, IUCT-Oncopôle Institut Claudius Regaud, Toulouse, France.; Rolland F; Department of Medical Oncology, Integrated Centers of Oncology (ICO) René Gauducheau, Nantes, France.; Blanc E; Department of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France.; Lefort F; Department of Medical Oncology, University Hospital of Bordeaux, Bordeaux, France.; Ravaud A; Department of Medical Oncology, University Hospital of Bordeaux, Bordeaux, France.; Gross-Goupil M; Department of Medical Oncology, University Hospital of Bordeaux, Bordeaux, France.; Escudier B; Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; U1015 INSERM, Gustave Roussy Cancer Campus, Paris-Saclay University, Villejuif, France.; Negrier S; Department of Medical Oncology, Lyon I University, Lyon, France.; Albiges L; Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France Laurence.ALBIGES@gustaveroussy.fr.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Strauss J; Center for Immuno-Oncology, National Cancer Institute, Bethesda, Maryland, USA.; Deville JL; Fédération de Cancérologie, Assistance Publique-Hôpitaux de Marseille, La Timone Hospital, Marseille, France.; Sznol M; Yale Cancer Center, Yale University, New Haven, Connecticut, USA.; Ravaud A; Department of Medical Oncology, Bordeaux University Hospital, Bordeaux, France.; Maruzzo M; Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV, IRCSS, Padua, Italy.; Pachynski RK; Division of Oncology, Washington University Medical School, St. Louis, Missouri, USA.; Gourdin TS; Department of Hematology Oncology, Medical University of South Carolina, Charleston, South Carolina, USA.; Maio M; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy.; Dirix L; Department of Oncology, GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp, Antwerpen, Belgium.; Schlom J; Center for Immuno-Oncology, National Cancer Institute, Bethesda, Maryland, USA.; Donahue RN; Center for Immuno-Oncology, National Cancer Institute, Bethesda, Maryland, USA.; Tsai YT; Center for Immuno-Oncology, National Cancer Institute, Bethesda, Maryland, USA.; Wang X; EMD Serono Research & Development Institute, Inc, Billerica, Massachusetts, USA, an affiliate of Merck KGaA.; Vugmeyster Y; EMD Serono Research & Development Institute, Inc, Billerica, Massachusetts, USA, an affiliate of Merck KGaA.; Beier F; Merck Healthcare KGaA, Darmstadt, Germany.; Seebeck J; Merck Healthcare KGaA, Darmstadt, Germany.; Schroeder A; Merck Healthcare KGaA, Darmstadt, Germany.; Chennoufi S; Merck Healthcare KGaA, Darmstadt, Germany.; Gulley JL; Center for Immuno-Oncology, National Cancer Institute, Bethesda, Maryland, USA gulleyj@mail.nih.gov.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Ravaud A
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어